Serial urinary neopterin measurements reflect the disease course in patients with epithelial ovarian carcinoma treated with pclitaxe/platinum chemotherapy

Abstract

Increased concentrations of urinary neopterin, an indicator of systemic immune activation, have been reported in patients with cancer, including epithelial ovarian carcinoma.